ATE523210T1 - Zusammensetzungen auf silikongelbasis zur wundheilung und narbenreduktion - Google Patents

Zusammensetzungen auf silikongelbasis zur wundheilung und narbenreduktion

Info

Publication number
ATE523210T1
ATE523210T1 AT08836714T AT08836714T ATE523210T1 AT E523210 T1 ATE523210 T1 AT E523210T1 AT 08836714 T AT08836714 T AT 08836714T AT 08836714 T AT08836714 T AT 08836714T AT E523210 T1 ATE523210 T1 AT E523210T1
Authority
AT
Austria
Prior art keywords
wound healing
scars
reduction
silicone gel
based compositions
Prior art date
Application number
AT08836714T
Other languages
English (en)
Inventor
Irwin Palefsky
Ni Kita Wilson
Original Assignee
Meda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Ab filed Critical Meda Ab
Application granted granted Critical
Publication of ATE523210T1 publication Critical patent/ATE523210T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/48—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms
    • C08G77/50—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms by carbon linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/70—Siloxanes defined by use of the MDTQ nomenclature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT08836714T 2007-09-30 2008-09-30 Zusammensetzungen auf silikongelbasis zur wundheilung und narbenreduktion ATE523210T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99716607P 2007-09-30 2007-09-30
PCT/US2008/078340 WO2009046033A2 (en) 2007-09-30 2008-09-30 Silicone gel-based compositions for wound healing and scar reduction

Publications (1)

Publication Number Publication Date
ATE523210T1 true ATE523210T1 (de) 2011-09-15

Family

ID=40336388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08836714T ATE523210T1 (de) 2007-09-30 2008-09-30 Zusammensetzungen auf silikongelbasis zur wundheilung und narbenreduktion

Country Status (26)

Country Link
US (2) US8563604B2 (de)
EP (1) EP2211919B1 (de)
JP (2) JP5449173B2 (de)
KR (1) KR101521669B1 (de)
CN (1) CN101854959B (de)
AT (1) ATE523210T1 (de)
AU (1) AU2008308849B2 (de)
BR (1) BRPI0817607A2 (de)
CA (1) CA2700382A1 (de)
DK (1) DK2211919T3 (de)
EA (1) EA017174B1 (de)
ES (1) ES2372127T3 (de)
GE (1) GEP20125661B (de)
HR (1) HRP20110896T1 (de)
IL (1) IL204002A (de)
ME (1) ME01258B (de)
MX (1) MX2010003503A (de)
PH (1) PH12013502430A1 (de)
PL (1) PL2211919T3 (de)
PT (1) PT2211919E (de)
RS (1) RS52070B (de)
SI (1) SI2211919T1 (de)
TW (1) TW200932292A (de)
UA (1) UA101812C2 (de)
WO (1) WO2009046033A2 (de)
ZA (1) ZA201002201B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089464A1 (en) * 2000-05-23 2001-11-29 Unilever Plc Deodorant and/or antiperspirant compositions
CN1234426C (zh) * 2001-07-24 2006-01-04 先进生物技术公司 局部用药物制剂
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20100124539A1 (en) * 2006-10-16 2010-05-20 Hanson Medical, Inc. Cosmetic preparations
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
CA2700382A1 (en) 2007-09-30 2009-04-09 Valeant Pharmaceuticals International Silicone gel-based compositions for wound healing and scar reduction
US20100322875A1 (en) 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
EP2482788B1 (de) 2009-10-02 2022-12-14 Journey Medical Corporation Topische tetracyclinzusammensetzungen
BE1019220A3 (nl) 2010-06-30 2012-04-03 Sylphar Huidverzorgingsproduct voor het behandelen van littekens.
US8491941B1 (en) 2011-01-25 2013-07-23 Tec Laboratories, Inc. Rash treatment with scar prevention
US9511077B2 (en) 2011-04-25 2016-12-06 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for wound healing
US9592243B2 (en) 2011-04-25 2017-03-14 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for treatment of an injury
CN102210886A (zh) * 2011-06-08 2011-10-12 湖南恒邦医疗科技有限公司 一种祛疤凝胶组合物及其制备方法
US20130144225A1 (en) * 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
US9592241B2 (en) 2011-12-27 2017-03-14 Cmpd Licensing, Llc Silicone-based composition for skin treatment
CN103191459B (zh) * 2013-04-06 2014-08-06 广东泰宝医疗科技股份有限公司 一种复合硅凝胶护创敷料及其制备方法
JPWO2014175444A1 (ja) * 2013-04-26 2017-02-23 千葉県 抗ｎｌｒｒ１抗体
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9511034B1 (en) 2013-12-09 2016-12-06 Bio-Silicote, Inc. Method for applying a skin treatment
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
EP3226976A1 (de) 2014-12-04 2017-10-11 Mary Kay, Inc. Topische hautpflegezusammesetzung mit trifluoroacetyl-tripeptid-2
CN104784211A (zh) * 2015-04-10 2015-07-22 浙江省诸暨市珠力神医用品有限公司 一种用于疤痕治疗及皮肤抗衰老的硅凝胶组合物
CN105168045B (zh) * 2015-09-07 2018-07-17 天津嘉氏堂科技有限公司 一种疤痕防晒修复硅凝胶及制备方法
CH712832B1 (de) 2016-08-24 2020-04-30 Drossapharm Ag Zusammensetzung für die Verwendung als Wundverband.
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
KR101921727B1 (ko) * 2016-12-28 2018-11-23 주식회사 제네웰 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
US12036353B2 (en) 2017-07-29 2024-07-16 Edward D. Lin Apparatus and methods for pressure management within a wound chamber
US10729826B2 (en) 2017-07-29 2020-08-04 Edward D. Lin Wound cover apparatus and related methods of use
US11712373B2 (en) 2017-07-29 2023-08-01 Edward D. Lin Wound therapy apparatus with scar modulation properties and related methods
US10780201B2 (en) 2017-07-29 2020-09-22 Edward D. Lin Control apparatus and related methods for wound therapy delivery
US11559622B2 (en) 2017-07-29 2023-01-24 Edward D. Lin Deformation resistant wound therapy apparatus and related methods of use
CN109512710A (zh) 2017-09-18 2019-03-26 玫琳凯有限公司 化妆品组合物及方法
IT201800005140A1 (it) * 2018-05-08 2019-11-08 Giuseppe Leonardo Federico Tessuto per la realizzazione di indumenti e bendaggi di compressione ed indumento contenitivo realizzato con detto tessuto
KR102234063B1 (ko) * 2018-11-28 2021-03-31 주식회사 현대바이오랜드 흉터개선용 피복 필름 형성을 위한 이액형 겔 조성물
CN113631141A (zh) 2019-03-01 2021-11-09 瓦塞尔曼梅迪奇公司 新组合物及其用途
CN110403839A (zh) * 2019-09-05 2019-11-05 河南汇博医疗股份有限公司 疤痕修复乳霜及其制备方法和应用
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition
CA3199914A1 (en) * 2020-11-25 2022-06-02 Steven M. Hernandez Scar treatment composition
CN113304126B (zh) * 2021-06-03 2024-11-22 杭州归领医疗器械有限公司 高粘性疤痕贴的生产方法
CN114917402B (zh) * 2022-04-21 2023-08-15 江西省科学院应用化学研究所 单组分光固化型抗菌硅凝胶医用材料及其制备方法和应用
CN115177548A (zh) * 2022-08-03 2022-10-14 克莱丽缇(上海)企业发展有限公司 一种维c组合物及其在护肤品中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
GB9922752D0 (en) * 1999-09-27 1999-11-24 Smith & Nephew Medical devices and treatment and prophylaxis
JP4236831B2 (ja) * 2001-07-31 2009-03-11 花王株式会社 滑水性を有する化粧料
GB0216427D0 (en) * 2002-07-16 2002-08-21 Advanced Biotechnologies Inter Wound dressing
JP2005029524A (ja) * 2003-07-09 2005-02-03 Harasawa Pharmaceutical Co Ltd シリコーンを主成分とする皮膚外用剤
US20050100568A1 (en) * 2003-11-12 2005-05-12 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions and methods for reducing the appearance of pores
CA2700382A1 (en) 2007-09-30 2009-04-09 Valeant Pharmaceuticals International Silicone gel-based compositions for wound healing and scar reduction

Also Published As

Publication number Publication date
JP2014055170A (ja) 2014-03-27
EA017174B1 (ru) 2012-10-30
US8563604B2 (en) 2013-10-22
CA2700382A1 (en) 2009-04-09
SI2211919T1 (sl) 2012-02-29
ES2372127T3 (es) 2012-01-16
TW200932292A (en) 2009-08-01
JP2010540563A (ja) 2010-12-24
EA201000574A1 (ru) 2010-10-29
ME01258B (me) 2013-06-20
US8859618B2 (en) 2014-10-14
PT2211919E (pt) 2011-12-05
MX2010003503A (es) 2010-04-21
CN101854959A (zh) 2010-10-06
US20140023610A1 (en) 2014-01-23
PH12013502430A1 (en) 2015-12-02
KR101521669B1 (ko) 2015-05-19
US20090143333A1 (en) 2009-06-04
AU2008308849A1 (en) 2009-04-09
CN101854959B (zh) 2014-03-19
WO2009046033A2 (en) 2009-04-09
JP5449173B2 (ja) 2014-03-19
RS52070B (sr) 2012-06-30
IL204002A (en) 2012-02-29
UA101812C2 (ru) 2013-05-13
AU2008308849B2 (en) 2014-04-24
BRPI0817607A2 (pt) 2014-10-14
KR20100075583A (ko) 2010-07-02
ZA201002201B (en) 2011-01-26
DK2211919T3 (da) 2011-12-12
EP2211919A2 (de) 2010-08-04
GEP20125661B (en) 2012-10-10
PL2211919T3 (pl) 2012-02-29
HRP20110896T1 (hr) 2011-12-31
WO2009046033A3 (en) 2010-02-25
EP2211919B1 (de) 2011-09-07

Similar Documents

Publication Publication Date Title
ZA201002201B (en) Silicone gel-based compositions for wound healing and scar reduction
EP3412220C0 (de) Chirurgische klemmen und applikatorinstrumente für den einsatz von chirurgischen klemmen
CO6351784A2 (es) Formas cristalinas de dimetoxi-docetaxel y sus procedimeintos de preparacion
EP2640359A4 (de) Neue zusammensetzungen und verwendungen blutdrucksenkender mittel zur krebstherapie
BRPI1015336A2 (pt) composições para tratamento de tecidos que compreendem polímeros de organossiloxano
BRPI0716210A2 (pt) Métodos, composições e aparelhos para tratar feridas com pressões diferentes da atmosférica
BRPI0907924A2 (pt) Agarradeira para instrumento cirúrgico e conjunto de instrumentos cirúrgicos.
ATE481990T1 (de) Implantierbare medizinprodukte aus verzweigten polymeren
EP1981457A4 (de) Chirurgische wundauflage
EP2195039A4 (de) Chirurgisches hydrogel
BR112012031626A2 (pt) composição adesiva sensível á pressão para aplicação na pele, construção adesiva com camada, e, dispositivo médico
EA201290381A1 (ru) Применение содержащего тритерпены олеогеля для заживления ран
GB201020193D0 (en) Glucan compositions
UA108631C2 (xx) Радіоімунокон'югати та їх застосування
IN2012DN01434A (de)
EP3646770A4 (de) Endoskopschlauch, endoskopartige medizinische vorrichtung, harzzusammensetzung zur beschichtung von endoskopschlauchsubstrat und harzzusammensetzungssatz zur beschichtung von endoskopschlauchsubstrat
BRPI1008821A2 (pt) Uso de uma fonte de dióxido de cloro
CY1119274T1 (el) Μια μεθοδος και συνθεση για την καταπολεμηση εκτοπαρασιτων
EP3801463A4 (de) Therapeutische zusammensetzungen zur besseren heilung von wunden und narben
EP3831312C0 (de) Chirurgisches instrument und lineares klammergerät
ATE501717T1 (de) Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms)
PL2288744T3 (pl) Połączenie błony i hydrożelu na bazie chitozanu i jego zastosowania w chirurgii
MY161460A (en) Elastomeric dental floss
CY1121680T1 (el) Υλικο για την προληψη των ελκων κατακλισης
UY32654A (es) Compuestos 1-(2-alquil-2,3-dihidro-benzofuran-4-il)-pirrolidin-3-ilaminoacilo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2211919

Country of ref document: EP